A Case for Immunization of Human Papillomavirus (HPV) 6/11-Infected Pregnant Women With the Quadrivalent HPV Vaccine to Prevent Juvenile-Onset Laryngeal Papilloma

Annual Report to the Nation on the Status of Cancer, 1975–2009, Featuring the Burden and Trends in Human Papillomavirus (HPV)–Associated Cancers and HPV Vaccination Coverage Levels

(2013) Ahmedin Jemal et al.   JNCI-Journal of the National Cancer Institute

Mother-Infant Transfer of Anti-Human Papillomavirus (HPV) Antibodies following Vaccination with the Quadrivalent HPV (Type 6/11/16/18) Virus-Like Particle Vaccine

(2012) Katie Matys et al.   Clinical and Vaccine Immunology

Vaccines in Pregnant Women and Research Initiatives

(2012) C. MARY HEALY   CLINICAL OBSTETRICS AND GYNECOLOGY

Estimates of the annual direct medical costs of the prevention and treatment of disease associated with human papillomavirus in the United States

(2012) Harrell W. Chesson et al.   VACCINE

Human Papillomavirus (HPV) 6, 11, 16, and 18 Prevalence Among Females in the United States—National Health and Nutrition Examination Survey, 2003–2006: Opportunity to Measure HPV Vaccine Impact?

(2011) Eileen F. Dunne et al.   JOURNAL OF INFECTIOUS DISEASES

Impact of Human Papillomavirus (HPV)-6/11/16/18 Vaccine on All HPV-Associated Genital Diseases in Young Women

(2010) Nubia Muñoz et al.   JNCI-Journal of the National Cancer Institute

Pregnancy and Infant Outcomes in the Clinical Trials of a Human Papillomavirus Type 6/11/16/18 Vaccine

(2009) Suzanne M. Garland et al.   OBSTETRICS AND GYNECOLOGY